CABA Cabaletta Bio Inc: Net earnings per share for the last 12 months

Public company logo of Cabaletta Bio Inc. (CABA)

The asset value tracked on the chart in the context of CAR-T platform scaling and asset protection is 43.20. Cabaletta Bio, Inc. (CABA) relies on the success of CABA-201 trials against systemic pathologies, which creates opportunities for an acquisition by industry behemoths. However, sanctions and political fragmentation hinder the movement of biomaterials and the conduct of global medical research, limiting patient access to therapy.

CABA Cabaletta Bio Inc. Earnings per share for the last twelve months (02/11/2024 - 11/12/2026)

Cabaletta Bio, Inc - analytical breakdowns and key metrics (CABA)

- market value and analyst target forecast:
Stock Quotes cabalettabio.com|CABA - Price Target Chart
- company stock capitalization data:
Market Valuation Cabaletta Bio Inc.|CABA - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Cabaletta Bio, Inc.|CABA - Company Book Value|Capitalization to Book Value Ratio cabalettabio.com|CABA - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Cabaletta Bio, Inc.|CABA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Cabaletta Bio Inc|CABA - Company Aggregate Debts|Debts to Book Capitalization Cabaletta Bio Inc.|CABA - Company Long-Term Debts|Company Short-Term Debt Cabaletta Bio, Inc.|Quick Ratio cabalettabio.com
- earnings and multiples data:
CABA - Company Net Income|Expected Profit Cabaletta Bio, Inc.|CABA - P/E Multiple|Projected Price to Earnings Ratio Cabaletta Bio Inc.|CABA - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Cabaletta Bio Inc.|CABA - Operating profit before deduction of amortization|Earnings per share for the last four quarters Cabaletta Bio, Inc.|CABA - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth cabalettabio.com|CABA - Net earnings per share growth this year|Expected earnings per share trend next year Cabaletta Bio, Inc.
Fundamental company valuation:CABA - cabalettabio.com
Core merchandise of Cabaletta Bio, Inc.

This metric reflects the year-over-year growth rate of earnings per share over the last 12 months. By analyzing the 12-month YoY EPS trend, an investor can distinguish actual operational efficiency from temporary accounting adjustments. This process helps identify hidden margin compression masked by Non-GAAP reporting. For Cabaletta Bio, Inc. (CABA), such transparency is critical when scaling trials through external vendors.

Competitor analysis for Cabaletta Bio, Inc.

argenx.com (ARGX) - Net earnings per share for the last 12 months|BioNTech (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax Corp|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) Protagonist Corp|Earnings per share for the last twelve months Immunovant, Inc. (IMVT)|kiniksa.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (Grifols)|Adaptive Biotech (ADPT) - Net earnings per one share for the last twelve months|Celldex - Net earnings per share (EPS TTM)|Aurinia Corp (AUPH) - Net earnings per share for the last 12 months|BCRX: Net earnings per share (EPS TTM)|veratx.com (VERA) - Net earnings per share (EPS TTM)|DNTH (Dianthus Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months PHVS|Net earnings per share (EPS TTM) ABCL|Net earnings per share (EPS TTM) Tourmaline (TRML)|Earnings per share for the last twelve months Precigen, Inc. PGEN|pharming.com - Earnings per share for the last twelve months|Nektar Therapeutics Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Net earnings per share for the last 12 months|IMNM: Earnings per share for the last four quarters|Net earnings per share for the last 12 months GOSS|KALV (kalvista.com) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) SEPN|Net earnings per share (EPS TTM) Pieris Pharma (PVLA)|Savara Corp - Net earnings per share for the last 12 months|Earnings per share for the trailing year RIGL|AnaptysBio, Inc. - Net earnings per share (EPS TTM)|ATXS: Earnings per share for the last twelve months|ENGN: Net earnings per share (EPS TTM)|RAPT - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Aerovate Therapeutics, Inc.|Net earnings per one share for the last twelve months Aclaris Therapeutics, Inc ACRS|Net earnings per share for the last 12 months KYTX (Kyverna Therapeutics)|TLSA (tizianalifesciences.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) VTYX (Ventyx Biosciences, Inc.)|Net earnings per share for the last four quarters Theratechnologies, Inc. (THTX)|AVTX - Earnings per share for the last twelve months|ELDN (Eledon Pharmaceuticals, Inc) - Earnings per share for the last 12 months|AGEN: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months climbbio.com|Net earnings per share for the last 12 months ZURA|aTyr Pharma Inc (ATYR) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) ADAG|Net earnings per share for the last 12 months ikenaoncology.com IMA|Net earnings per share (EPS TTM) STTK (Shattuck Labs)|Net earnings per share (EPS TTM) Equillium Inc EQ|Connect Pharma - Net earnings per share (EPS TTM)|IMUX: Earnings per share for the last twelve months|ATRA: Net earnings per share (EPS TTM)|InflaRx (IFRX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months X4 Pharmaceuticals|Adicet - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CELU|INMB (INmune Bio Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) BRNS (Barinthus Bio)|Net earnings per share (EPS TTM) Kezar Life Sciences Inc KZR|SABS - Earnings per share for the last twelve months|Earnings per share for the trailing year AKTX (akaritx.com)|enlivex.com (ENLV) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Q32 Bio|GOVX (GeoVax Labs Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Edesa Biotech Corp|Net earnings per share for the last 12 months IBIO (iBio, Inc.)|CARM (carismatx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) XTLB (XTL Biopharmaceuticals Ltd.)|Net earnings per share for the last four quarters Bolt Biotherapeutics Inc. (BOLT)|HCWB - Earnings per share for the last twelve months|Aptevo Therapeutics (APVO) - Net earnings per share for the last 12 months|AIM ImmunoTech (AIM) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Aditxt, Inc.|Net earnings per share for the last 12 months GRI|Net earnings per share (EPS TTM) XORTX Therapeutics Inc|Earnings per share for the last twelve months ReShape Lifesciences (HIND)|Revelation Biosciences Corp - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) INDP (Indaptus Therapeutics)|scinai.com (SCNI) - Net earnings per one share for the last twelve months|CalciMedica Corp - Net earnings per share (EPS TTM)|Affimed (AFMD) - Net earnings per share for the last 12 months|ALLK: Net earnings per share (EPS TTM)|HOOKIPA Pharma (HOOK) - Net earnings per share (EPS TTM)|IGMS (IGM Biosciences Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ITOS|Net earnings per share (EPS TTM) OCEA|Net earnings per share (EPS TTM) TC BioPharm (Holdings) Plc (TCBP)|Earnings per share for the last twelve months Third Harmonic Bio, Inc THRD